CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Aripiprazole 1 mg/mL Oral Suspension
This may be suitable for patients who cannot take the solid oral dosage forms or tolerate the ingredients in the commercially available oral solution.
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Malignant Hyperthermia: An Overview
Malignant hyperthermia must be treated rapidly to avoid fatality, and despite its rarity, healthcare facilities that use known triggering agents must be fully prepared to treat it.
Copyright © 2000 - 2025 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.